RE:PROXY VOTE AGAINSTGood luck goldtech a few Boston group shareholders will easily push this through they control this company. I don't understand the Sphera comments ? Total institutional shares at the time of last financing was 10.9%, will see 45 days after sep 30 updated numbers but i doubt much of a change.
If Promis goes into the clinic testing alzheimers patients it will take many years to prove the science not just promising or encouraging interim results.
Alzheon the alzheimers pill looks strong and encouraging and may headed for approvals, will see this fall. This could be a game changer.
Roche also this fall Prrasinezmab with Parkinsons Prothena
Prothena this fall PRX012 update, they have pushed off topline results